Galderma Group AG (SWX:GALD)
174.25
-0.75 (-0.43%)
Oct 21, 2026, 5:31 PM CEST
Galderma Group AG Employees
Galderma Group AG had 7,676 employees as of December 31, 2025. The number of employees increased by 1,131 or 17.28% compared to the previous year. That makes Galderma Group AG the 4,124th largest employer in the world and 50th in Switzerland.
Employees
7,676
Change
1,131
Growth
17.28%
Revenue / Employee
623.47K CHF
Profits / Employee
90.84K CHF
Market Cap
40.63B
Employees Chart
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 7,676 | 1,131 | 17.28% |
| Dec 31, 2023 | 6,545 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Roche Holding AG | 103,249 |
| Novartis AG | 75,267 |
| Alcon | 25,000 |
| Lonza Group AG | 20,141 |
| Sandoz Group AG | 20,000 |
| Sonova Holding AG | 18,590 |
| Straumann Holding AG | 11,582 |
| Galenica AG | 6,623 |
Galderma Group AG News
- 1 day ago - AMWC Dubai 2026: Galderma Reinforces Its Injectable Aesthetics Leadership - Business Wire
- 8 days ago - Galderma to Buy ZO Skin Health for $1.5 Billion - WSJ
- 8 days ago - Galderma Signs Agreement to Acquire ZO Skin Health, Strengthening Its Physician-Dispensed Skincare Offering - Business Wire
- 9 days ago - New Galderma Research Reveals More Than Half of Women Mistake Menopause-Related Skin Changes for Signs of Ageing - Business Wire
- 14 days ago - Fall Clinical 2026: Galderma Presents New Three-Year Nemluvio® Data Showing Deep and Lasting Skin Lesion and Itch Responses in Patients With Atopic Dermatitis Aged 12 and Older - Business Wire
- 22 days ago - EADV 2026: Galderma's New Data Show Sustained Improvements with Nemluvio® (nemolizumab) for up to Three Years in Patients With Moderate-to-severe Atopic Dermatitis - Business Wire
- 4 weeks ago - EADV 2026: Galderma to Unveil New Data Advancing Understanding of Skin Diseases, Skin Longevity, and Real-world Patient Experiences - Business Wire
- 4 weeks ago - Galderma mindful of focus while eyeing product range expansion, CEO tells FuW - Reuters